Levin, Papantonio shareholder Tim O'Brien informs the Fosamax Examiner that closing arguments are set for Tuesday, April 17, in the New Jersey Fosamax bellwether trial in the case of Jo Ann Sessner vs. Merck & Co.. The case involves the claim of a Florida Fosamax patient who developed Stage 3 bisphosphonate-related osteonecrosis of the jaw after more than six years of Fosamax use. O'Brien has been trying the case with Douglas & London attorney, Gary Douglas, for the last two months, in the Superior Court of New Jersey Law Division: Atlantic County, Docket No. ATL-L-3394-11-MT.
Closing Arguments Set For Tuesday, April 17